EX-10.9 15 d128073dex109.htm EX-10.9 ADVISORY BOARD MEMBER AGREEMENT Seth Rudnick, M.D. Dear Dr. Rudnick:Advisory Board Member Agreement • May 5th, 2020 • North Carolina
Contract Type FiledMay 5th, 2020 JurisdictionThis ADVISORY BOARD MEMBER AGREEMENT (the “Agreement”), is made and entered into as of this 15th day of July 2016 and effective as of July 1, 2016 (the “Effective Date”), by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and you. This Agreement replaces that certain Advisory Board Member Agreement, effective July 1, 2014, by and between the Company and you, which expired by its terms on June 30, 2016.
ADVISORY BOARD MEMBER AGREEMENTAdvisory Board Member Agreement • April 13th, 2017 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledApril 13th, 2017 Company Industry JurisdictionThis ADVISORY BOARD MEMBER AGREEMENT (the “Agreement”), is made and entered into as of this 15th day of July 2016 and effective as of July 1, 2016 (the “Effective Date”), by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and you. This Agreement replaces that certain Advisory Board Member Agreement, effective July 1, 2014, by and between the Company and you, which expired by its terms on June 30, 2016.
ADVISORY BOARD MEMBER AGREEMENTAdvisory Board Member Agreement • February 9th, 2017 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledFebruary 9th, 2017 Company Industry JurisdictionThis ADVISORY BOARD MEMBER AGREEMENT (the “Agreement”), is made and entered into as of this 15th day of July 2016 and effective as of July 1, 2016 (the “Effective Date”), by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and you. This Agreement replaces that certain Advisory Board Member Agreement, effective July 1, 2014, by and between the Company and you, which expired by its terms on June 30, 2016.